Article
Selectivity of the time-dependent <i>M. tuberculosis</i> LeuRS inhibitor ganfeborole is driven by target vulnerability
2025-08-03
Abstract excerpt
<h4>ABSTRACT</h4> Ganfeborole (GSK3036656) inhibits the Mycobacterium tuberculosis leucyl-tRNA-synthetase (mtLeuRS) and is in phase 2a clinical trials for the treatment of tuberculosis. Here we show that ganfeborole is a time-dependent inhibitor of mtLeuRS (IC 50 1 nM) and generates a post-antibiotic effect of 77 h at 50xMIC (MIC 0.058 μM) with M. tuberculosis H37Rv ( Mtb ), indicating that mtLeuRS is a highl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c02f376e-97a9-5745-bded-5fa7684778b1
- DOI
- 10.1101/2025.07.31.667927
